Skip to main content

Patients with early stage breast cancer who have evaluation of the axilla

CBE ID
0222
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

Percentage of women with Stage I-IIb breast cancer that received either axillary node dissection or Sentinel Lymph Node Biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy)

        • 1.14 Numerator

          Number of women in the denominator that received either axillary node dissection or SLNB at the time of surgical resection of the primary tumor.

        • 1.15 Denominator

          Number of women with diagnosis of stage I-IIb breast cancer that received either lumpectomy or mastectomy

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cancer Endorsement Maintenance Project
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          Intermountain Healthcare
          Steward Organization POC Email